{"address1": "100 King Street West", "address2": "Suite 5600", "city": "Toronto", "state": "ON", "zip": "M5X 1C9", "country": "Canada", "website": "https://www.cybin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 1/2a clinical trial to treat major depressive disorder (MDD), as well as in preclinical trials for alcohol use disorder; CYB004, a deuterated dimethyltryptamine (DMT), which completed phase 2 clinical trial for treating generalized anxiety disorders; SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 completed phase 1, 1b, and 1/2a for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation, as well as has a research pipeline of investigational psychedelic-based compounds. The company has research and collaboration agreement with TMS Neurohealth Centers Inc. for development of psychedelic compound-based therapeutics; Kernel for use of Kernel flow technology to measure neural activity; and Greenbook TMS to establish mental health centers. It also has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  So L.L.B.", "age": 48, "title": "Co-Founder, President & Executive Chairman", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 508616, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas L. Drysdale", "age": 54, "title": "Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 720432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Glavine", "age": 34, "title": "Co-Founder, Chief Growth Officer & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 508616, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Cavers", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 312674, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Bartlone", "age": 57, "title": "Chief Operating Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 430733, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Tziras", "age": 43, "title": "Chief Business Officer & Director", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Kanakis", "age": 43, "title": "Co-Founder", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 665202, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alex L. Nivorozhkin Ph.D.", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lori  Challenger", "title": "Chief Compliance, Ethics & Administrative Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gabriel  Fahel", "age": 48, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.34, "open": 6.37, "dayLow": 5.8147, "dayHigh": 6.37, "regularMarketPreviousClose": 6.34, "regularMarketOpen": 6.37, "regularMarketDayLow": 5.8147, "regularMarketDayHigh": 6.37, "payoutRatio": 0.0, "beta": 0.978, "forwardPE": -1.2236024, "volume": 350139, "regularMarketVolume": 350139, "averageVolume": 263810, "averageVolume10days": 179090, "averageDailyVolume10Day": 179090, "bid": 5.72, "ask": 7.3, "bidSize": 12, "askSize": 9, "marketCap": 134141632, "fiftyTwoWeekLow": 5.81, "fiftyTwoWeekHigh": 17.86, "fiftyDayAverage": 8.4348, "twoHundredDayAverage": 9.6096, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -11967701, "profitMargins": 0.0, "floatShares": 18315557, "sharesOutstanding": 21016900, "sharesShort": 1090476, "sharesShortPriorMonth": 835208, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0509, "heldPercentInsiders": 2.38237, "heldPercentInstitutions": 0.41933998, "shortRatio": 3.37, "impliedSharesOutstanding": 22697400, "bookValue": 12.005, "priceToBook": 0.49229485, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -103904000, "trailingEps": -3.47, "forwardEps": -4.83, "lastSplitFactor": "1:38", "lastSplitDate": 1726704000, "enterpriseToEbitda": 0.089, "52WeekChange": -0.66409004, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 5.91, "targetHighPrice": 149.92563, "targetLowPrice": 24.772173, "targetMeanPrice": 78.92291, "targetMedianPrice": 72.93035, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 136290000, "totalCashPerShare": 6.479, "ebitda": -134963008, "totalDebt": 0, "quickRatio": 10.662, "currentRatio": 12.603, "returnOnAssets": -0.44061002, "returnOnEquity": -0.57491, "freeCashflow": -59445248, "operatingCashflow": -100894000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CYBN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cybin Inc.", "corporateActions": [], "preMarketTime": 1743597336, "regularMarketTime": 1743537600, "exchange": "ASE", "messageBoardId": "finmb_666815486", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -2.5248003, "fiftyDayAverageChangePercent": -0.29933137, "twoHundredDayAverageChange": -3.6996002, "twoHundredDayAverageChangePercent": -0.38499004, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cybin, Inc.", "nameChangeDate": "2025-04-01", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1568381400000, "preMarketChange": -0.099999905, "preMarketChangePercent": -1.6920458, "preMarketPrice": 5.81, "regularMarketChange": -0.43, "regularMarketDayRange": "5.8147 - 6.37", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 263810, "fiftyTwoWeekLowChange": 0.099999905, "fiftyTwoWeekLowChangePercent": 0.017211687, "fiftyTwoWeekRange": "5.81 - 17.86", "fiftyTwoWeekHighChange": -11.950001, "fiftyTwoWeekHighChangePercent": -0.66909295, "fiftyTwoWeekChangePercent": -66.409004, "earningsTimestampStart": 1644526800, "earningsTimestampEnd": 1644526800, "epsTrailingTwelveMonths": -3.47, "epsForward": -4.83, "epsCurrentYear": -3.85, "priceEpsCurrentYear": -1.5350649, "longName": "Cybin Inc.", "regularMarketChangePercent": -6.78234, "regularMarketPrice": 5.91, "displayName": "Cybin", "trailingPegRatio": null}